Issue 9/2023
Content (11 Articles)
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?
Elizabeth Sakach, Merve Keskinkilic, Sarah Wood, Madison Canning, Kevin Kalinsky
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
Naomi Dempsey, Ana Sandoval, Reshma Mahtani
Open Access
Nasopharyngeal Cancer
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
Juan Jose Juarez-Vignon Whaley, Michelle Afkhami, Mykola Onyshchenko, Erminia Massarelli, Sagus Sampath, Arya Amini, Diana Bell, Victoria M. Villaflor
Antibody Drug Conjugates in Bladder Cancer: Current Milestones and Future Perspectives
Raafat Alameddine, Patrick Mallea, Farhan Shahab, Yousef Zakharia
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials
Benjamin L. Maughan, Deepika Sirohi
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
Amisha Singh, Appledene S. Osbourne, Vadim S. Koshkin
The Evolving Treatment Landscape of Merkel Cell Carcinoma
Neha Singh, Erin M. McClure, Tomoko Akaike, Song Y. Park, Emily T. Huynh, Peter H. Goff, Paul Nghiem
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers
Zejie Tian, Hui Li, Zhenhua Liu, Lingyan Yang, Chaoyang Zhang, Jun He, Wenbin Ai, Yunmei Liu
Open Access
Brain Tumor
Management of Thromboembolic Disease in Patients with Primary and Metastatic Brain Tumors
Ryan R. Woods, Glenn J. Lesser